Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2012
06/06/2012CN101213187B Isoquinoline derivatives as inhibitors of RHO-kinase
06/06/2012CN101039933B Diaminotriazole compounds useful as protein kinase inhibitors
06/05/2012US8193363 Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193205 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
06/05/2012US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
06/05/2012US8193192 Heterocyclic FXR binding compounds
06/05/2012US8193165 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
06/05/2012US8191802 Aerosol
06/05/2012CA2671816C Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
06/05/2012CA2571019C 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/05/2012CA2540163C Thrombin receptor antagonists
06/05/2012CA2520000C Compositions and methods for treating cancer
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
05/2012
05/31/2012WO2012071414A2 Quinoxaline compounds and uses thereof
05/31/2012WO2012070226A1 Oxygenated fused ring derivative and organic electroluminescence element containing the same
05/31/2012WO2012070024A1 Carbonic anhydrase inhibitors with antimetastatic activity
05/31/2012WO2012069989A1 Process for preparation of clevidipine and its intermediate
05/31/2012WO2012069601A1 Substituted quinazolines as fungicides
05/31/2012WO2012069428A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
05/31/2012WO2012069366A1 Insecticidal compounds
05/31/2012WO2012069025A1 (5-methyl-2-oxo-1,3-dioxol-4-ylmethyl)-4-(1-hydroxy-1-methyl-propyl)-2-propyl-1-[2'- (1h-tetrazol-5-yl)biphenyl-4-yl-methyl]imidazole-5-carboxylate as an impurity of olmesartan medoxomil and a method of its preparation
05/31/2012WO2012068879A1 High photosensibility carbazole oxime ester photoinitiator,preparation and use thereof
05/31/2012WO2011162562A3 [6+5] fused bicycles as a thrombin antagonist, process for preparation thereof and pharmaceutical compositions containing the bicycles
05/31/2012US20120136151 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
05/31/2012US20120136150 4-(3-Butynyl)Aminopyrimidine Derivatives as Pest Control Agents for Agricultural and Horticultural Use
05/31/2012US20120136148 Photochromic Compounds Having At Least Two Photochromic Moieties
05/31/2012US20120136048 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
05/31/2012US20120136027 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120136018 Quinolines
05/31/2012US20120135992 Cyclic triazo sodium channel blockers
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120132870 Indeno-Fused Naphthopyrans Having Ethylenically Unsaturated Groups
05/31/2012CA2856812A1 Carbonic anhydrase inhibitors with antimetastatic activity
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2456761A2 Potent small molecule inhibitors of autophagy and methods of use thereof
05/30/2012EP2456436A1 3-phenoxymethylpyrrolidine compounds
05/30/2012EP2137166B1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
05/30/2012EP1771453B1 Hepatitis c inhibitor dipeptide analogs
05/30/2012CN102482265A 用于治疗增殖性疾病的吡嗪基吡啶化合物 For the treatment of proliferative diseases pyrazinyl pyridine compounds
05/30/2012CN102482264A 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
05/30/2012CN102482263A 苄基哌啶化合物 Benzylpiperidine compound
05/30/2012CN102482249A Tofa analogs useful in treating dermatological disorders or conditions
05/30/2012CN102482244A Covalent inhibition of bacterial quorum sensing
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN102482231A 磺酰胺和磺基肟-取代的二芳基-二氢嘧啶酮和其应用 Sulfonamides and sulfonamide oxime - substituted diaryl - dihydro-pyrimidone and their applications
05/30/2012CN102482227A 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物 As the γ-secretase modulators substituted triazole and imidazole derivatives
05/30/2012CN102482222A 2-azatriphenylene materials for organic light emitting diodes
05/30/2012CN102482221A 作为katii抑制剂的双环和三环化合物 Bicyclic and tricyclic compounds as inhibitors katii
05/30/2012CN102482219A 吡喃酮和吡啶酮衍生物的制备方法 And the preparation of pyrone derivatives of the pyridone
05/30/2012CN102477032A 2-cyclopropyl-4-substituted-phenoxy-quinoline derivatives, and its preparation method, intermediate and application
05/30/2012CN101735202B Azimilide dihydrochloride crystal form I as well as preparation method and application thereof
05/30/2012CN101735201B Preparation method of piribedil
05/30/2012CN101686968B Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
05/30/2012CN101657418B Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
05/30/2012CN101611014B Acylaminopyrazoles as FGFR inhibitors
05/30/2012CN101550119B Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing same
05/30/2012CN101516366B Oxindole derivatives as anticancer agents
05/30/2012CN101479260B Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
05/30/2012CN101460468B 2-pyrazinecarboxamide derivatives
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/30/2012CN101248044B Novel indole compounds
05/29/2012USRE43431 Quinazoline derivatives and pharmaceutical compositions containing them
05/29/2012US8188324 Coating interior surface of chemical reactor with lithium aluminum hydride; supplying carbon dioxide; reduction; reacting with hydrogen iodide
05/29/2012US8188301 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
05/29/2012US8188276 2,4-pyrimidinediamine compounds and their uses
05/29/2012US8188103 Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012US8188089 Tylophorine analogs as antitumor agents
05/29/2012US8188085 Antifungal agents
05/29/2012CA2543831C Process for preparing thiazolidinediones
05/29/2012CA2512605C Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2481036C (3z)-(3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
05/29/2012CA2463966C Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/29/2012CA2318731C Ppar-gamma modulators
05/24/2012WO2012068366A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
05/24/2012WO2012068234A2 Antiviral compounds
05/24/2012WO2012067963A1 Nampt inhibitors
05/24/2012WO2012066122A1 2 - (pyridin- 2 -yl) -quinazoline derivatives and their use as microbicides
05/24/2012WO2012065947A1 5-halogenopyrazolecarboxamides
05/24/2012WO2012065568A1 Azo heterocyclic compound having insecticidal activity, and preparation and applications thereof
05/24/2012WO2011051540A8 Androgen receptor modulating compounds
05/24/2012US20120130082 1-Substituted-4-Nitroimidazole Compound and Method for Preparing the Same
05/24/2012US20120130077 Benzyl piperidine compound
05/24/2012US20120130076 Synthetic Multimerizing Agents
05/24/2012US20120130069 Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129854 Pesticidal Arylpyrrolidines
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129828 S1p1 receptor agonists and use thereof
05/24/2012US20120129818 Compositions and Methods for Treatment of Cardiovascular Disease
05/24/2012US20120129813 Novel compounds as receptor modulators with therapeutic utility
05/24/2012US20120129812 Novel thyroid hormone beta receptor agonist
05/24/2012US20120128630 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharamaceutical composition thereof and their therapeutic use
05/24/2012US20120126185 Indeno-fused ring compounds
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 694